Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
mRNA-1273 Emergency use authorization Experimental Vaccine Apr/02/2021 18 0
BNT162b2 Emergency use authorization Experimental Vaccine Apr/02/2021 33 0
BBV152 Emergency use authorization Experimental Vaccine Mar/27/2021 7 0
Mefuparib hydrochloride Potential treatment - pre-clinical evidence Experimental Antiviral Mar/26/2021 1 0
CoV-X2 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/25/2021 1 0
Temsirolimus Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/25/2021 3 0
Torin 2 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/25/2021 3 0
Vistusertib Potential treatment - pre-clinical evidence Experimental Antiviral Mar/25/2021 2 0
Everolimus Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/25/2021 3 0
Rapamycin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/25/2021 6 0